Book a free demo with us
Book Now
MNDL Bio
MNDL Bio is a Synthetic Biology startup aiming to reduce cost and production time of food and biotech applications through advanced computational platforms that optimize gene expression.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2023
Tel Aviv, Israel
ISR
Biotechnology
Biotech
Genetic
Bioinformatics
- 
https://www.mndl.bio/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
MNDL Bio's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Social Media
© 2024 Lucidity Insights.
